Walla Al-Hertani MD MS, FRCPC, FCCMG, FACMG (She/Her)
Clinical Biochemical Genetics, Clinical Genetics, Medical Biochemical Genetics, Pediatric Medical Genetics
Division Chief, Metabolic Disorders Division
Join to View Full Profile
1201 W La Veta AveOrange, CA 92868
Phone+1 714-509-4873
Fax+1 714-509-4788
Dr. Al-Hertani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Division Chief and Medical Director of the Metabolic Disorders Division at CHOC. Previously Harvey Levy Endowed Chair in Metabolism, Director of the Metabolism, Lysosomal and Glycogen Storage Disease programs at Boston Children's Hospital. MD degree from Dalhousie University; Medical Genetics Residency at University of Ottawa/CHEO; Biochemical Genetics Fellowship at University of Toronto/SickKids.
Education & Training
University of Toronto/Hospital for Sick Children (SickKids)FCCMG, Biochemical Genetics, 2010 - 2012- University of Ottawa/Children’s Hospital of Eastern Ontario (CHEO)FRCPC, FCCMG, Medical Genetics, 2005 - 2010
Dalhousie University Faculty of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2024 - 2026
MA State Medical License 2019 - 2025
NC State Medical License 2020 - 2022
ME State Medical License 2020 - 2021
RI State Medical License 2020 - 2020
Awards, Honors, & Recognition
- Postgraduate Mentorship Award Cummings School of Medicine/University of Calgary, 2019
- Postgraduate Teaching Award McGill University, 2014
- Humanitarian Award Hospital for Sick Children/SickKids/SickKids Foundation, 2011
- Join now to see all
Clinical Trials
- Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia Start of enrollment: 2021 Apr 15
Roles: Principal Investigator
- Early Access Program With Arimoclomol in US Patients With NPC
Roles: Contact
Publications & Presentations
PubMed
- Levacetylleucine (N-acetyl-l-leucine) for Niemann-Pick disease type C.Raquel van Gool, Walla Al-Hertani, Olaf Bodamer, Jaymin Upadhyay
Trends in Pharmacological Sciences. 2025-04-01 - Implications of the choroid plexus in Niemann-Pick disease Type C neuropathogenesis.Raquel van Gool, Mariesa Cay, Boyu Ren, Kailey Brodeur, Emma Golden
Brain, Behavior, and Immunity. 2025-02-01 - Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review.Walla Al-Hertani, Ravi R Pathak, Obaro Evuarherhe, Gemma Carter, Carolyn R Schaeffer-Koziol
International Journal of Molecular Sciences. 2024-08-06
Press Mentions
Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsNovember 18th, 2021
External Links
- LinkedInhttp://www.linkedin.com/in/hertanw
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
